MM

Manoj Manu

Active Director Director DIN 08151904
DIN 08151904 First appointment Jun 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2018
Shareholding value •••• Premium profile

About Manoj Manu

Data last updated:

Manoj Manu is a Director at Globax Pharma Private Limited (since 2018). The company operates in Pharma. Globax Pharma Private Limited reported revenue of ₹13 Lakh (FY 2020).

DIN 08151904
Primary Designation Director
Industry Pharma
First Appointment 07 Jun 2018
Oldest Company Age 11 yrs
Largest company Globax Pharma Private Limited · ₹13 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Globax Pharma Private Limited U51909DL2015PTC285428
Director07 Jun 20182015₹13 Lakh (FY 2020)Active

Board colleagues of Manoj Manu

NameDINCompanyDesignation
Preeti Panchal07198338Globax Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Globax Pharma Private Limited
Premium access

Shareholding and investment profile for Manoj Manu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manoj Manu

Manoj Manu currently holds 1 directorship: Globax Pharma Private Limited (Director, since 07 Jun 2018, revenue ₹13 Lakh (FY 2020)).

Manoj Manu was first appointed on 07 Jun 2018 as Director at Globax Pharma Private Limited.

The current boards of Manoj Manu's companies include Preeti Panchal (Globax Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available